ProMIS Neurosciences
PMN
13 hedge funds and large institutions have $724K invested in ProMIS Neurosciences in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
8% more funds holding
Funds holding: 12 → 13 (+1)
0% less ownership
Funds ownership: 0.09% → 0.09% (-0%)
19% less capital invested
Capital invested by funds: $889K → $724K (-$165K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.72K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.59K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$6.38K |
| 2 |
Morgan Stanley
New York
|
-$3.72K |
| 3 |
JP Morgan Chase
New York
|
-$1.59K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NFC
1
Northeast Financial Consultants
Westport,
Connecticut
| $388K | – | – | – |
|
|
IC
2
IEQ Capital
Foster City,
California
| $152K | – | – | – |
|
|
3
Bank of America
Charlotte,
North Carolina
| $52.4K | -$6.38K | -48 | -8% |
|
|
CAM
4
Claret Asset Management
Montreal,
Quebec, Canada
| $47K | – | – | – |
|
|
FT
5
Fiduciary Trust
Boston,
Massachusetts
| $39.4K | – | – | – |
|
|
6
JP Morgan Chase
New York
| $19K | -$1.59K | -12 | -6% |
|
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| $10K | +$1.59K | +12 | +14% |
|
|
8
Morgan Stanley
New York
| $7.01K | -$3.72K | -28 | -28% |
|
|
GCM
9
Gables Capital Management
Miami,
Florida
| $3.23K | – | – | – |
|
|
10
UBS Group
Zurich,
Switzerland
| $2.73K | +$3.72K | +28 | New |
|
11
National Bank of Canada
Montreal,
Quebec, Canada
| $1.26K | – | – | – |
|
|
AWM
12
AllSquare Wealth Management
Albany,
New York
| $931 | – | – | – |
|
|
TWC
13
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $745 | – | – | – |
|
PMN Hedge Fund Activity: Q2 2023 in Review
13 of the 6,371 institutional investors tracked by Wall St. Rank reported a position in ProMIS Neurosciences (PMN) for Q2 2023, worth a combined $724K — down 19% from $889K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PMN positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $3.72K. The largest seller was Bank of America, cutting an estimated $6.38K.
- 13 institutional investors held ProMIS Neurosciences (PMN) as of Q2 2023, up from 12 in Q1 2023.
- Funds reported $724K of ProMIS Neurosciences stock for Q2 2023, down 19% quarter-over-quarter.
- 1 fund opened new ProMIS Neurosciences positions in Q2 2023 and 0 closed out, a net change of +1 holder.
- The largest ProMIS Neurosciences buyer in Q2 2023 was UBS Group, an estimated $3.72K added.
- The largest ProMIS Neurosciences seller in Q2 2023 was Bank of America, an estimated $6.38K sold.
Based on aggregated 13F filings for Q2 2023.